Skip to main content
. 2022 Mar 29;6(7):2055–2068. doi: 10.1182/bloodadvances.2020004142

Figure 1.

Figure 1.

Patient selection. Inclusion and exclusion criteria for analysis. Patients excluded from analysis at time of first competing event after CAR T-cell infusion, defined as relapse with marrow involvement, new cytotoxic therapy, second lymphodepletion or CAR T-cell infusion, death, or loss to follow-up.